ORBIS INVESTMENT MANAGEMENT LTD
Holdings History for CRISPR Therapeutics AG - Common Stock (CRSP)
- Symbol
- CRSP on Nasdaq
- Investment type
- Equity / Common Stock
- Latest Disclosed Shares Owned
- 5,934,328 shares
- Security Ownership %
- 6.2%
ORBIS INVESTMENT MANAGEMENT LTD ownership in CRISPR Therapeutics AG Common Stock (CRSP)
17 Feb 2026 - ORBIS INVESTMENT MANAGEMENT LTD has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,934,328 shares of CRISPR Therapeutics AG Common Stock (CRSP).
This represents 6.2% ownership of the company.
In their previous filing dated 14 Nov 2025, ORBIS INVESTMENT MANAGEMENT LTD had reported owning 4,974,125 shares, indicating an increase of +19%.
.
| Reporting Name | Ownership % | Change | Value $ | Shares owned | Change | Activity % | Price | Form | Report date | Filing time |
|---|---|---|---|---|---|---|---|---|---|---|
| ORBIS INVESTMENT MANAGEMENT LTD | 6.2% | +12% | $328,168,338 | 5,934,328 | +960,203 | +19% | $55.30 | 13G/A | 31 Dec 2025 | 17 Feb 2026, 12:06 |
| ORBIS INVESTMENT MANAGEMENT LTD | 5.5% | $322,373,041 | 4,974,125 | $64.81 | 13G | 30 Sep 2025 | 14 Nov 2025, 12:26 |